<DOC>
	<DOCNO>NCT00160173</DOCNO>
	<brief_summary>This study intend establish low effective dose EstroGelÂ® treatment vasomotor symptom associate menopause .</brief_summary>
	<brief_title>Efficacy Study Comparing 0.9 g 1.25 g Estrogel With Placebo Vasomotor Symptoms Vulvar Vaginal Atrophy</brief_title>
	<detailed_description />
	<mesh_term>Atrophy</mesh_term>
	<mesh_term>Estradiol</mesh_term>
	<criteria>Women 4565 year naturally surgically postmenopausal experience hot flush hypersensitivity estrogen replacement therapy pregnancy lactate abnormal PAP smear history/suspected cervical , uterine , adrenal , pituitary , breast ovarian malignancy</criteria>
	<gender>Female</gender>
	<minimum_age>45 Years</minimum_age>
	<maximum_age>65 Years</maximum_age>
	<verification_date>July 2013</verification_date>
	<keyword>Post menopausal vasomotor symptom</keyword>
</DOC>